(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ALLERGEAZE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ALLERGEAZE

ST13

US500000077124190

Class

5

Filing

77124190

Registration

3497726

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

05/24/2024

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

03/07/2007

Registration date

09/09/2008

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/18/2018

Last transaction

05/24/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

01/31/2007

First use in commerce

01/31/2007

Drawing code

4

Owner type

03

Owner location

Phoenix, AZ, US

Examiner

COLLIER, DAVID E

Law office

L40

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

SmartHealth, Inc.

Representatives

Daniel E. Kattman, Esq. REINHART BOERNER VAN DEUREN S.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Patch test systems comprising epicutaneous contact allergenspatch test chamberschamber coversreading guidesskin markersclinic boxespatch traysdata collection forms and allergy health history forms all used for diagnostic allergy tests in the field of dermatology

Publications

History of USPTO decisions and trademark events.

32 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/18/2018

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/18/2018

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/18/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/18/2018

E89R

TEAS SECTION 8 & 9 RECEIVED

09/11/2018

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/09/2017

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

09/19/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/19/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/19/2014

E815

TEAS SECTION 8 & 15 RECEIVED

09/09/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

09/09/2008

PUBO

PUBLISHED FOR OPPOSITION

06/24/2008

NPUB

NOTICE OF PUBLICATION

06/04/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/20/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/20/2008

XAEC

EXAMINER'S AMENDMENT ENTERED

05/20/2008

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/20/2008

GNEA

EXAMINERS AMENDMENT E-MAILED

05/20/2008

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/20/2008

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

05/20/2008

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

03/28/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/17/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/15/2008

ACEC

AMENDMENT FROM APPLICANT ENTERED

02/14/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/14/2008

ALIE

ASSIGNED TO LIE

02/14/2008

MAIL

PAPER RECEIVED

01/14/2008

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/11/2007

GNRT

NON-FINAL ACTION E-MAILED

07/11/2007

CNRT

NON-FINAL ACTION WRITTEN

07/11/2007

DOCK

ASSIGNED TO EXAMINER

06/20/2007

NWAP

NEW APPLICATION ENTERED

03/12/2007

Continuous trademark protection

Get notified about every new filing that threatens ALLERGEAZE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.